| Year |
Citation |
Score |
| 2020 |
Fourniols T, Bastien E, Canevat A, Feron O, Préat V. Inhibition of colorectal cancer-associated fibroblasts by lipid nanocapsules loaded with acriflavine or paclitaxel. International Journal of Pharmaceutics. 584: 119337. PMID 32371002 DOI: 10.1016/J.Ijpharm.2020.119337 |
0.336 |
|
| 2020 |
Spillier Q, Ravez S, Unterlass J, Corbet C, Degavre C, Feron O, Frédérick R. Structure-Activity Relationships (SARs) of α-Ketothioamides as Inhibitors of Phosphoglycerate Dehydrogenase (PHGDH). Pharmaceuticals (Basel, Switzerland). 13. PMID 31979167 DOI: 10.3390/Ph13020020 |
0.308 |
|
| 2020 |
Corbet C, Bastien E, Santiago de Jesus JP, Dierge E, Martherus R, Vander Linden C, Doix B, Degavre C, Guilbaud C, Petit L, Michiels C, Dessy C, Larondelle Y, Feron O. TGFβ2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells. Nature Communications. 11: 454. PMID 31974393 DOI: 10.1038/S41467-019-14262-3 |
0.301 |
|
| 2019 |
Schoonjans CA, Joudiou N, Brusa D, Corbet C, Feron O, Gallez B. Acidosis-induced metabolic reprogramming in tumor cells enhances the anti-proliferative activity of the PDK inhibitor dichloroacetate. Cancer Letters. 470: 18-28. PMID 31812695 DOI: 10.1016/J.Canlet.2019.12.003 |
0.344 |
|
| 2019 |
Bevernaegie R, Doix B, Bastien E, Diman AEL, Decottignies A, Feron O, Elias B. Exploring the photo-toxicity of hypoxic active iridium(III)-based sensitizers in 3D tumor spheroids. Journal of the American Chemical Society. PMID 31644286 DOI: 10.1021/Jacs.9B07723 |
0.314 |
|
| 2019 |
Dierge E, Feron O. Dealing with saturated and unsaturated fatty acid metabolism for anticancer therapy. Current Opinion in Clinical Nutrition and Metabolic Care. 22: 427-433. PMID 31589175 DOI: 10.1097/Mco.0000000000000601 |
0.303 |
|
| 2019 |
Doix B, Trempolec N, Riant O, Feron O. Low Photosensitizer Dose and Early Radiotherapy Enhance Antitumor Immune Response of Photodynamic Therapy-Based Dendritic Cell Vaccination. Frontiers in Oncology. 9: 811. PMID 31508370 DOI: 10.3389/Fonc.2019.00811 |
0.32 |
|
| 2019 |
Spillier Q, Vertommen D, Ravez S, Marteau R, Thémans Q, Corbet C, Feron O, Wouters J, Frédérick R. Anti-alcohol abuse drug disulfiram inhibits human PHGDH via disruption of its active tetrameric form through a specific cysteine oxidation. Scientific Reports. 9: 4737. PMID 30894617 DOI: 10.1038/S41598-019-41187-0 |
0.316 |
|
| 2019 |
Wang H, Jiang H, Corbet C, de Mey S, Law K, Gevaert T, Feron O, De Ridder M. Piperlongumine increases sensitivity of colorectal cancer cells to radiation: involvement of ROS production via dual inhibition of glutathione and thioredoxin systems. Cancer Letters. PMID 30790679 DOI: 10.1016/J.Canlet.2019.02.034 |
0.364 |
|
| 2018 |
Aboubakar Nana F, Lecocq M, Ladjemi MZ, Detry B, Dupasquier S, Feron O, Massion PP, Sibille Y, Pilette C, Ocak S. Therapeutic potential of Focal Adhesion Kinase inhibition in small cell lung cancer. Molecular Cancer Therapeutics. PMID 30352800 DOI: 10.1158/1535-7163.Mct-18-0328 |
0.32 |
|
| 2018 |
de Mey S, Jiang H, Corbet C, Wang H, Dufait I, Law K, Bastien E, Verovski V, Gevaert T, Feron O, De Ridder M. Antidiabetic Biguanides Radiosensitize Hypoxic Colorectal Cancer Cells Through a Decrease in Oxygen Consumption. Frontiers in Pharmacology. 9: 1073. PMID 30337872 DOI: 10.3389/Fphar.2018.01073 |
0.361 |
|
| 2018 |
Corbet C, Bastien E, Draoui N, Doix B, Mignion L, Jordan BF, Marchand A, Vanherck JC, Chaltin P, Schakman O, Becker HM, Riant O, Feron O. Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects. Nature Communications. 9: 1208. PMID 29572438 DOI: 10.1038/S41467-018-03525-0 |
0.34 |
|
| 2018 |
De Mey S, Wang H, Heng J, Dufait I, Law K, Corbet C, Verovski V, Gevaert T, Feron O, De Ridder M. EP-2310: Phenformin radiosensitizes hypoxic tumor cells through inhibition of mitochondrial complex Radiotherapy and Oncology. 127: S1275. DOI: 10.1016/S0167-8140(18)32619-7 |
0.313 |
|
| 2017 |
Bindels LB, Porporato PE, Ducastel S, Sboarina M, Neyrinck AM, Dewulf EM, Feron O, Lestavel S, Cani PD, Staels B, Sonveaux P, Delzenne NM. Ffar2 expression regulates leukaemic cell growth in vivo. British Journal of Cancer. 117: 1336-1340. PMID 28873082 DOI: 10.1038/Bjc.2017.307 |
0.306 |
|
| 2017 |
De Pauw A, Andre E, Sekkali B, Bouzin C, Esfahani H, Barbier N, Loriot A, De Smet C, Vanhoutte L, Moniotte S, Gerber B, di Mauro V, Catalucci D, Feron O, Hilfiker-Kleiner D, et al. Dnmt3a-mediated inhibition of Wnt in cardiac progenitor cells improves differentiation and remote remodeling after infarction. Jci Insight. 2. PMID 28614798 DOI: 10.1172/Jci.Insight.91810 |
0.535 |
|
| 2017 |
Danhier P, Deumer G, Joudiou N, Bouzin C, Levêque P, Haufroid V, Jordan BF, Feron O, Sonveaux P, Gallez B. Contribution of macrophages in the contrast loss in iron oxide-based MRI cancer cell tracking studies. Oncotarget. PMID 28467814 DOI: 10.18632/Oncotarget.17103 |
0.326 |
|
| 2017 |
Wang H, Bouzakoura S, de Mey S, Jiang H, Law K, Dufait I, Corbet C, Verovski V, Gevaert T, Feron O, Van den Berge D, Storme G, De Ridder M. Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species. Oncotarget. PMID 28415723 DOI: 10.18632/Oncotarget.16113 |
0.369 |
|
| 2017 |
Corbet C, Feron O. Emerging roles of lipid metabolism in cancer progression. Current Opinion in Clinical Nutrition and Metabolic Care. 20: 254-260. PMID 28403011 DOI: 10.1097/Mco.0000000000000381 |
0.328 |
|
| 2017 |
Vanhoutte L, Guilbaud C, Martherus R, Bouzin C, Gallez B, Dessy C, Balligand JL, Moniotte S, Feron O. MRI Assessment of Cardiomyopathy Induced by β1-Adrenoreceptor Autoantibodies and Protection Through β3-Adrenoreceptor Overexpression. Scientific Reports. 7: 43951. PMID 28276515 DOI: 10.1038/Srep43951 |
0.51 |
|
| 2016 |
Neveu MA, De Preter G, Joudiou N, Bol A, Brender JR, Saito K, Kishimoto S, Grégoire V, Jordan BF, Krishna MC, Feron O, Gallez B. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models. Oncotarget. 7: 81741-81749. PMID 28082726 DOI: 10.18632/Oncotarget.13176 |
0.377 |
|
| 2016 |
Fruytier AC, Le Duff CS, Po C, Magat J, Bouzin C, Neveu MA, Feron O, Jordan BF, Gallez B. The Blood Flow Shutdown Induced by Combretastatin A4 Impairs Gemcitabine Delivery in a Mouse Hepatocarcinoma. Frontiers in Pharmacology. 7: 506. PMID 28066252 DOI: 10.3389/Fphar.2016.00506 |
0.334 |
|
| 2016 |
Neveu MA, De Preter G, Marchand V, Bol A, Brender JR, Saito K, Kishimoto S, Porporato PE, Sonveaux P, Grégoire V, Feron O, Jordan BF, Krishna MC, Gallez B. Multimodality Imaging Identifies Distinct Metabolic Profiles In Vitro and In Vivo. Neoplasia (New York, N.Y.). 18: 742-752. PMID 27889643 DOI: 10.1016/J.Neo.2016.10.010 |
0.324 |
|
| 2016 |
Corbet C, Pinto A, Martherus R, Santiago de Jesus JP, Polet F, Feron O. Acidosis Drives the Reprogramming of Fatty Acid Metabolism in Cancer Cells through Changes in Mitochondrial and Histone Acetylation. Cell Metabolism. 24: 311-23. PMID 27508876 DOI: 10.1016/J.Cmet.2016.07.003 |
0.348 |
|
| 2016 |
Vanhoutte L, Gerber BL, Gallez B, Po C, Magat J, Balligand JL, Feron O, Moniotte S. Erratum to: High field magnetic resonance imaging of rodents in cardiovascular research. Basic Research in Cardiology. 111: 55. PMID 27492500 DOI: 10.1007/S00395-016-0572-3 |
0.483 |
|
| 2016 |
Michiels C, Tellier C, Feron O. Cycling hypoxia: A key feature of the tumor microenvironment. Biochimica Et Biophysica Acta. 1866: 76-86. PMID 27343712 DOI: 10.1016/J.Bbcan.2016.06.004 |
0.351 |
|
| 2016 |
Romero M, Leon-Gomez E, Lobysheva I, Rath G, Dogné JM, Feron O, Dessy C. Effects of BM-573 on Endothelial Dependent Relaxation and Increased Blood Pressure at Early Stages of Atherosclerosis. Plos One. 11: e0152579. PMID 27019366 DOI: 10.1371/Journal.Pone.0152579 |
0.349 |
|
| 2016 |
Corbet C, Ragelle H, Pourcelle V, Vanvarenberg K, Marchand-Brynaert J, Préat V, Feron O. Delivery of siRNA targeting tumor metabolism using non-covalent PEGylated chitosan nanoparticles: Identification of an optimal combination of ligand structure, linker and grafting method. Journal of Controlled Release : Official Journal of the Controlled Release Society. 223: 53-63. PMID 26699426 DOI: 10.1016/J.Jconrel.2015.12.020 |
0.318 |
|
| 2015 |
Pinto A, Mace Y, Drouet F, Bony E, Boidot R, Draoui N, Lobysheva I, Corbet C, Polet F, Martherus R, Deraedt Q, Rodríguez J, Lamy C, Schicke O, Delvaux D, ... ... Feron O, et al. A new ER-specific photosensitizer unravels (1)O2-driven protein oxidation and inhibition of deubiquitinases as a generic mechanism for cancer PDT. Oncogene. PMID 26686091 DOI: 10.1038/Onc.2015.474 |
0.348 |
|
| 2015 |
Polet F, Corbet C, Pinto A, Rubio LI, Martherus R, Bol V, Drozak X, Grégoire V, Riant O, Feron O. Reducing the serine availability complements the inhibition of the glutamine metabolism to block leukemia cell growth. Oncotarget. PMID 26625201 DOI: 10.18632/Oncotarget.6426 |
0.348 |
|
| 2015 |
Vanhoutte L, Gallez B, Feron O, Balligand JL, Esfahani H, d'Hoore W, Moniotte S. Variability of Mouse Left Ventricular Function Assessment by 11.7 Tesla MRI. Journal of Cardiovascular Translational Research. 8: 362-71. PMID 26070905 DOI: 10.1007/S12265-015-9638-0 |
0.508 |
|
| 2015 |
Tellier C, Desmet D, Petit L, Finet L, Graux C, Raes M, Feron O, Michiels C. Cycling hypoxia induces a specific amplified inflammatory phenotype in endothelial cells and enhances tumor-promoting inflammation in vivo. Neoplasia (New York, N.Y.). 17: 66-78. PMID 25622900 DOI: 10.1016/J.Neo.2014.11.003 |
0.357 |
|
| 2015 |
Fruytier AC, Magat J, Neveu MA, Karroum O, Bouzin C, Feron O, Jordan B, Cron GO, Gallez B. Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4. Nmr in Biomedicine. 27: 1403-12. PMID 25323069 DOI: 10.1002/Nbm.3220 |
0.316 |
|
| 2015 |
Bol V, Bol A, Bouzin C, Labar D, Lee JA, Janssens G, Porporato PE, Sonveaux P, Feron O, Grégoire V. Reprogramming of tumor metabolism by targeting mitochondria improves tumor response to irradiation. Acta Oncologica (Stockholm, Sweden). 54: 266-74. PMID 25007226 DOI: 10.3109/0284186X.2014.932006 |
0.343 |
|
| 2015 |
Macé Y, Bony E, Delvaux D, Pinto A, Mathieu V, Kiss R, Feron O, Quetin-Leclercq J, Riant O. Cytotoxic activities and metabolic studies of new combretastatin analogues Medicinal Chemistry Research. 24: 3143-3156. DOI: 10.1007/S00044-015-1363-3 |
0.337 |
|
| 2014 |
Corbet C, Draoui N, Polet F, Pinto A, Drozak X, Riant O, Feron O. The SIRT1/HIF2α axis drives reductive glutamine metabolism under chronic acidosis and alters tumor response to therapy. Cancer Research. 74: 5507-19. PMID 25085245 DOI: 10.1158/0008-5472.Can-14-0705 |
0.352 |
|
| 2014 |
Porporato PE, Payen VL, Pérez-Escuredo J, De Saedeleer CJ, Danhier P, Copetti T, Dhup S, Tardy M, Vazeille T, Bouzin C, Feron O, Michiels C, Gallez B, Sonveaux P. A mitochondrial switch promotes tumor metastasis. Cell Reports. 8: 754-66. PMID 25066121 DOI: 10.1016/J.Celrep.2014.06.043 |
0.339 |
|
| 2014 |
Draoui N, Schicke O, Seront E, Bouzin C, Sonveaux P, Riant O, Feron O. Antitumor activity of 7-aminocarboxycoumarin derivatives, a new class of potent inhibitors of lactate influx but not efflux. Molecular Cancer Therapeutics. 13: 1410-8. PMID 24672058 DOI: 10.1158/1535-7163.Mct-13-0653 |
0.373 |
|
| 2014 |
Danhier P, De Preter G, Magat J, Godechal Q, Porporato PE, Jordan BF, Feron O, Sonveaux P, Gallez B. Multimodal cell tracking of a spontaneous metastasis model: comparison between MRI, electron paramagnetic resonance and bioluminescence. Contrast Media & Molecular Imaging. 9: 143-53. PMID 24523059 DOI: 10.1002/Cmmi.1553 |
0.319 |
|
| 2014 |
De Saedeleer CJ, Porporato PE, Copetti T, Pérez-Escuredo J, Payen VL, Brisson L, Feron O, Sonveaux P. Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration Oncogene. 33: 4060-4068. PMID 24166504 DOI: 10.1038/Onc.2013.454 |
0.367 |
|
| 2014 |
de Meester C, Timmermans AD, Balteau M, Ginion A, Roelants V, Noppe G, Porporato PE, Sonveaux P, Viollet B, Sakamoto K, Feron O, Horman S, Vanoverschelde JL, Beauloye C, Bertrand L. Role of AMP-activated protein kinase in regulating hypoxic survival and proliferation of mesenchymal stem cells. Cardiovascular Research. 101: 20-9. PMID 24104879 DOI: 10.1093/Cvr/Cvt227 |
0.307 |
|
| 2014 |
Porporato PE, Payen VL, Pérez-Escuredo J, Danhier P, Feron O, Gallez B, Sonveaux P. Abstract 4035: A mitochondrial switch promotes tumor metastasis Cancer Research. 74: 4035-4035. DOI: 10.1158/1538-7445.Am2014-4035 |
0.357 |
|
| 2014 |
Vanhoutte L, Esfahani H, Feron O, Balligand J, Gallez B, Moniotte S. P781Assessment of the accuracy and reproducibility of left ventricular mass and volumes measurements in mice using an 11.7T MRI machine Cardiovascular Research. 103: S143.4-S143. DOI: 10.1093/Cvr/Cvu098.199 |
0.516 |
|
| 2014 |
Vanhoutte L, Esfahani H, Feron O, Balligand J, Bernard G, Moniotte S. 0331: Left ventricular systolic function assessment in a mouse model of cardiac hypertrophy using an 11.7T MRI scanner and comparison with ex-vivo measurements Archives of Cardiovascular Diseases Supplements. 6: 62. DOI: 10.1016/S1878-6480(14)71431-4 |
0.524 |
|
| 2014 |
Timmermans A, Meester CD, Balteau M, Ginion A, Roelants V, Noppe G, Porporato P, Sonveaux P, Viollet B, Sakamoto K, Feron O, Horman S, Vanoverschelde J, Beauloye C, Bertrand L. 0311: Role of AMP-activated protein kinase in regulating proliferation of mesenchymal stem cells Archives of Cardiovascular Diseases Supplements. 6: 49. DOI: 10.1016/S1878-6480(14)71396-5 |
0.319 |
|
| 2014 |
Michiels C, Tellier C, Graux C, Finet L, Raes M, Feron O. 171: Cycling hypoxia amplifies tumor microenvironment inflammation European Journal of Cancer. 50: S38. DOI: 10.1016/S0959-8049(14)50144-X |
0.301 |
|
| 2013 |
Grandjean M, Sermeus A, Branders S, Defresne F, Dieu M, Dupont P, Raes M, De Ridder M, Feron O. Hypoxia integration in the serological proteome analysis unmasks tumor antigens and fosters the identification of anti-phospho-eEF2 antibodies as potential cancer biomarkers. Plos One. 8: e76508. PMID 24130777 DOI: 10.1371/Journal.Pone.0076508 |
0.35 |
|
| 2013 |
Draoui N, Schicke O, Fernandes A, Drozak X, Nahra F, Dumont A, Douxfils J, Hermans E, Dogné JM, Corbau R, Marchand A, Chaltin P, Sonveaux P, Feron O, Riant O. Synthesis and pharmacological evaluation of carboxycoumarins as a new antitumor treatment targeting lactate transport in cancer cells. Bioorganic & Medicinal Chemistry. 21: 7107-17. PMID 24095010 DOI: 10.1016/J.Bmc.2013.09.010 |
0.313 |
|
| 2013 |
Grandjean M, Dieu M, Raes M, Feron O. A new method combining sequential immunoaffinity depletion and differential in gel electrophoresis to identify autoantibodies as cancer biomarkers. Journal of Immunological Methods. 396: 23-32. PMID 23916966 DOI: 10.1016/J.Jim.2013.07.006 |
0.332 |
|
| 2013 |
Hick AC, Delmarcelle AS, Bouquet M, Klotz S, Copetti T, Forez C, Van Der Smissen P, Sonveaux P, Collet JF, Feron O, Courtoy PJ, Pierreux CE. Reciprocal epithelial:endothelial paracrine interactions during thyroid development govern follicular organization and C-cells differentiation. Developmental Biology. 381: 227-40. PMID 23707896 DOI: 10.1016/J.Ydbio.2013.04.022 |
0.338 |
|
| 2013 |
Bury M, Andolfi A, Rogister B, Cimmino A, Mégalizzi V, Mathieu V, Feron O, Evidente A, Kiss R. Fusicoccin a, a phytotoxic carbotricyclic diterpene glucoside of fungal origin, reduces proliferation and invasion of glioblastoma cells by targeting multiple tyrosine kinases. Translational Oncology. 6: 112-23. PMID 23544164 DOI: 10.1593/Tlo.12409 |
0.326 |
|
| 2013 |
Riquier H, Wera AC, Heuskin AC, Feron O, Lucas S, Michiels C. Comparison of X-ray and alpha particle effects on a human cancer and endothelial cells: survival curves and gene expression profiles. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 106: 397-403. PMID 23540554 DOI: 10.1016/J.Radonc.2013.02.017 |
0.312 |
|
| 2013 |
Danhier P, Copetti T, De Preter G, Leveque P, Feron O, Jordan BF, Sonveaux P, Gallez B. Influence of cell detachment on the respiration rate of tumor and endothelial cells. Plos One. 8: e53324. PMID 23382841 DOI: 10.1371/Journal.Pone.0053324 |
0.355 |
|
| 2013 |
Polet F, Feron O. Endothelial cell metabolism and tumour angiogenesis: glucose and glutamine as essential fuels and lactate as the driving force. Journal of Internal Medicine. 273: 156-65. PMID 23216817 DOI: 10.1111/Joim.12016 |
0.371 |
|
| 2013 |
Vanhoutte L, Feron O, Balligand J, Gallez B, Esfahani H, Moniotte S. Intra-observer, inter-experiment and inter-observer variability of left ventricular volumes and mass measurements in mice using an 11.7 Tesla MRI Journal of Cardiovascular Magnetic Resonance. 15. DOI: 10.1186/1532-429X-15-S1-P282 |
0.52 |
|
| 2012 |
De Saedeleer CJ, Copetti T, Porporato PE, Verrax J, Feron O, Sonveaux P. Lactate activates HIF-1 in oxidative but not in Warburg-phenotype human tumor cells. Plos One. 7: e46571. PMID 23082126 DOI: 10.1371/Journal.Pone.0046571 |
0.408 |
|
| 2012 |
Rath G, Saliez J, Behets G, Romero-Perez M, Leon-Gomez E, Bouzin C, Vriens J, Nilius B, Feron O, Dessy C. Vascular hypoxic preconditioning relies on TRPV4-dependent calcium influx and proper intercellular gap junctions communication. Arteriosclerosis, Thrombosis, and Vascular Biology. 32: 2241-9. PMID 22814746 DOI: 10.1161/Atvbaha.112.252783 |
0.313 |
|
| 2012 |
Porporato PE, Payen VL, De Saedeleer CJ, Préat V, Thissen JP, Feron O, Sonveaux P. Lactate stimulates angiogenesis and accelerates the healing of superficial and ischemic wounds in mice. Angiogenesis. 15: 581-92. PMID 22660894 DOI: 10.1007/S10456-012-9282-0 |
0.326 |
|
| 2012 |
Mathieu V, de Lassalle EM, Toelen J, Mohr T, Bellahcène A, Van Goietsenoven G, Verschuere T, Bouzin C, Debyser Z, De Vleeschouwer S, Van Gool S, Poirier F, Castronovo V, Kiss R, Feron O. Galectin-1 in melanoma biology and related neo-angiogenesis processes. The Journal of Investigative Dermatology. 132: 2245-54. PMID 22622427 DOI: 10.1038/Jid.2012.142 |
0.382 |
|
| 2012 |
Danhier P, De Preter G, Boutry S, Mahieu I, Leveque P, Magat J, Haufroid V, Sonveaux P, Bouzin C, Feron O, Muller RN, Jordan BF, Gallez B. Electron paramagnetic resonance as a sensitive tool to assess the iron oxide content in cells for MRI cell labeling studies. Contrast Media & Molecular Imaging. 7: 302-7. PMID 22539400 DOI: 10.1002/Cmmi.497 |
0.306 |
|
| 2012 |
Danhier F, Pourcelle V, Marchand-Brynaert J, Jérôme C, Feron O, Préat V. Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles. Methods in Enzymology. 508: 157-75. PMID 22449925 DOI: 10.1016/B978-0-12-391860-4.00008-2 |
0.338 |
|
| 2012 |
Sonveaux P, Copetti T, De Saedeleer CJ, Végran F, Verrax J, Kennedy KM, Moon EJ, Dhup S, Danhier P, Frérart F, Gallez B, Ribeiro A, Michiels C, Dewhirst MW, Feron O. Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis. Plos One. 7: e33418. PMID 22428047 DOI: 10.1371/Journal.Pone.0033418 |
0.429 |
|
| 2012 |
Boidot R, Végran F, Meulle A, Le Breton A, Dessy C, Sonveaux P, Lizard-Nacol S, Feron O. Regulation of monocarboxylate transporter MCT1 expression by p53 mediates inward and outward lactate fluxes in tumors. Cancer Research. 72: 939-48. PMID 22184616 DOI: 10.1158/0008-5472.Can-11-2474 |
0.339 |
|
| 2012 |
Diepart C, Karroum O, Magat J, Feron O, Verrax J, Calderon PB, Grégoire V, Leveque P, Stockis J, Dauguet N, Jordan BF, Gallez B. Arsenic trioxide treatment decreases the oxygen consumption rate of tumor cells and radiosensitizes solid tumors. Cancer Research. 72: 482-90. PMID 22139377 DOI: 10.1158/0008-5472.Can-11-1755 |
0.31 |
|
| 2012 |
Nanka O, Krejci E, Pesevski Z, Sedmera D, Smart N, Rossdeutsch A, Dube KN, Riegler J, Price AN, Taylor A, Muthurangu V, Turner M, Lythgoe MF, Riley PR, Kryvorot S, ... ... Feron O, et al. Poster session 3 Cardiovascular Research. 93: S92-S127. DOI: 10.1093/Cvr/Cvr336 |
0.462 |
|
| 2012 |
Gérard E, Meulle A, Feron O, Marchand-Brynaert J. Diaryl ureaLDV peptidomimetics as α4β1integrin antagonists: synthesis, adhesion inhibition and toxicity evaluation on CCRF-CEM cell line Med. Chem. Commun.. 3: 199-212. DOI: 10.1039/C1Md00229E |
0.307 |
|
| 2011 |
Draoui N, Feron O. Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments. Disease Models & Mechanisms. 4: 727-32. PMID 22065843 DOI: 10.1242/Dmm.007724 |
0.387 |
|
| 2011 |
Radermacher KA, Magat J, Bouzin C, Laurent S, Dresselaers T, Himmelreich U, Boutry S, Mahieu I, Vander Elst L, Feron O, Muller RN, Jordan BF, Gallez B. Multimodal assessment of early tumor response to chemotherapy: comparison between diffusion-weighted MRI, 1H-MR spectroscopy of choline and USPIO particles targeted at cell death. Nmr in Biomedicine. 25: 514-22. PMID 21874657 DOI: 10.1002/Nbm.1765 |
0.311 |
|
| 2011 |
Lobysheva I, Rath G, Sekkali B, Bouzin C, Feron O, Gallez B, Dessy C, Balligand JL. Moderate caveolin-1 downregulation prevents NADPH oxidase-dependent endothelial nitric oxide synthase uncoupling by angiotensin II in endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology. 31: 2098-105. PMID 21659644 DOI: 10.1161/Atvbaha.111.230623 |
0.594 |
|
| 2011 |
Defresne F, Bouzin C, Grandjean M, Dieu M, Raes M, Hatzopoulos AK, Kupatt C, Feron O. Preconditioned endothelial progenitor cells reduce formation of melanoma metastases through SPARC-driven cell-cell interactions and endocytosis. Cancer Research. 71: 4748-57. PMID 21616936 DOI: 10.1158/0008-5472.Can-10-2449 |
0.385 |
|
| 2011 |
Verrax J, Defresne F, Lair F, Vandermeulen G, Rath G, Dessy C, Préat V, Feron O. Delivery of soluble VEGF receptor 1 (sFlt1) by gene electrotransfer as a new antiangiogenic cancer therapy. Molecular Pharmaceutics. 8: 701-8. PMID 21548585 DOI: 10.1021/Mp100268T |
0.395 |
|
| 2011 |
Daugimont L, Vandermeulen G, Defresne F, Bouzin C, Mir LM, Bouquet C, Feron O, Préat V. Antitumoral and antimetastatic effect of antiangiogenic plasmids in B16 melanoma: Higher efficiency of the recombinant disintegrin domain of ADAM 15. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. 78: 314-9. PMID 21316447 DOI: 10.1016/J.Ejpb.2011.02.001 |
0.33 |
|
| 2011 |
Végran F, Boidot R, Michiels C, Sonveaux P, Feron O. Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis. Cancer Research. 71: 2550-60. PMID 21300765 DOI: 10.1158/0008-5472.Can-10-2828 |
0.381 |
|
| 2011 |
des Rieux A, Ucakar B, Mupendwa BP, Colau D, Feron O, Carmeliet P, Préat V. 3D systems delivering VEGF to promote angiogenesis for tissue engineering. Journal of Controlled Release : Official Journal of the Controlled Release Society. 150: 272-8. PMID 21130820 DOI: 10.1016/J.Jconrel.2010.11.028 |
0.318 |
|
| 2011 |
Radermacher KA, Boutry S, Laurent S, Elst LV, Mahieu I, Bouzin C, Magat J, Gregoire V, Feron O, Muller RN, Jordan BF, Gallez B. Iron oxide particles covered with hexapeptides targeted at phosphatidylserine as MR biomarkers of tumor cell death. Contrast Media & Molecular Imaging. 5: 258-67. PMID 20973111 DOI: 10.1002/Cmmi.382 |
0.321 |
|
| 2011 |
Defresne F, Bouzin C, Grandjean M, Kupatt C, Hatzopoulos A, Feron O. 1068 POSTER Preconditioned Monocytic Endothelial Progenitor Cells Reduce Formation of Melanoma Metastases Through SPARC-driven Cell-cell Interactions European Journal of Cancer. 47: S115. DOI: 10.1016/S0959-8049(11)70711-0 |
0.333 |
|
| 2010 |
Danhier F, Feron O, Préat V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 148: 135-46. PMID 20797419 DOI: 10.1016/J.Jconrel.2010.08.027 |
0.327 |
|
| 2010 |
Defresne F, Bouzin C, Guilbaud C, Dieu M, Delaive E, Michiels C, Raes M, Feron O. Differential influence of anticancer treatments and angiogenesis on the seric titer of autoantibody used as tumor and metastasis biomarker. Neoplasia (New York, N.Y.). 12: 562-70. PMID 20651985 DOI: 10.1593/Neo.10238 |
0.331 |
|
| 2010 |
Feron O. Tumor-penetrating peptides: a shift from magic bullets to magic guns. Science Translational Medicine. 2: 34ps26. PMID 20519716 DOI: 10.1126/Scitranslmed.3001174 |
0.32 |
|
| 2010 |
Bouchat V, Nuttens VE, Michiels C, Masereel B, Feron O, Gallez B, Borght TV, Lucas S. Radioimmunotherapy with radioactive nanoparticles: biological doses and treatment efficiency for vascularized tumors with or without a central hypoxic area. Medical Physics. 37: 1826-1839. PMID 20443505 DOI: 10.1118/1.3368599 |
0.323 |
|
| 2010 |
Dessy C, Feron O, Balligand JL. The regulation of endothelial nitric oxide synthase by caveolin: a paradigm validated in vivo and shared by the 'endothelium-derived hyperpolarizing factor'. Pflugers Archiv : European Journal of Physiology. 459: 817-27. PMID 20339866 DOI: 10.1007/S00424-010-0815-3 |
0.588 |
|
| 2010 |
Jiang H, De Ridder M, Verovski VN, Sonveaux P, Jordan BF, Law K, Monsaert C, Van den Berge DL, Verellen D, Feron O, Gallez B, Storme GA. Activated macrophages as a novel determinant of tumor cell radioresponse: the role of nitric oxide-mediated inhibition of cellular respiration and oxygen sparing. International Journal of Radiation Oncology, Biology, Physics. 76: 1520-7. PMID 20338478 DOI: 10.1016/J.Ijrobp.2009.10.047 |
0.376 |
|
| 2010 |
Daneau G, Boidot R, Martinive P, Feron O. Identification of cyclooxygenase-2 as a major actor of the transcriptomic adaptation of endothelial and tumor cells to cyclic hypoxia: effect on angiogenesis and metastases. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 410-9. PMID 20068092 DOI: 10.1158/1078-0432.Ccr-09-0583 |
0.383 |
|
| 2010 |
Diepart C, Verrax J, Calderon PB, Feron O, Jordan BF, Gallez B. Comparison of methods for measuring oxygen consumption in tumor cells in vitro. Analytical Biochemistry. 396: 250-6. PMID 19766582 DOI: 10.1016/J.Ab.2009.09.029 |
0.309 |
|
| 2010 |
Ni J, McLoughlin RM, Brodovitch A, Moulin P, Brouckaert P, Casadei B, Feron O, Topley N, Balligand JL, Devuyst O. Nitric oxide synthase isoforms play distinct roles during acute peritonitis. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 25: 86-96. PMID 19706695 DOI: 10.1093/Ndt/Gfp415 |
0.485 |
|
| 2010 |
Robert S, Decrem Y, Rath G, Dessy C, Feron O, Mullier F, Chatelain B, Devel P, Dogné J, Godfroid E. The Tick Protein Ir-Cpi Efficiently Delays Contact Pathway Induced Thrombin Generation and Displays In Vivo Antithrombotic Activity Blood. 116: 3336-3336. DOI: 10.1182/Blood.V116.21.3336.3336 |
0.307 |
|
| 2010 |
Daneau G, Boidot R, Martinive P, Feron O. Abstract 461: Identification of COX-2 as a major actor of the transcriptomic adaptation of endothelial and tumor cells to cyclic hypoxia: impact on angiogenesis and metastases Cancer Research. 70: 461-461. DOI: 10.1158/1538-7445.Am10-461 |
0.408 |
|
| 2010 |
Radermacher K, Boutry S, Laurent S, Mahieu I, Vander Elst L, Bouzin C, Magat J, Grégoire V, Feron O, Muller R, Jordan B, Gallez B. 71 poster: Iron Oxide Particles Covered with Hexapeptides Targeted at Phosphatidylserine as MR Biomarkers of Tumor Cell Death Radiotherapy and Oncology. 94: S28-S29. DOI: 10.1016/S0167-8140(15)34490-X |
0.301 |
|
| 2009 |
Ansiaux R, Dewever J, Grégoire V, Feron O, Jordan BF, Gallez B. Decrease in tumor cell oxygen consumption after treatment with vandetanib (ZACTIMA; ZD6474) and its effect on response to radiotherapy. Radiation Research. 172: 584-91. PMID 19883226 DOI: 10.1667/Rr1744.1 |
0.336 |
|
| 2009 |
Decrem Y, Rath G, Blasioli V, Cauchie P, Robert S, Beaufays J, Frère JM, Feron O, Dogné JM, Dessy C, Vanhamme L, Godfroid E. Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis. The Journal of Experimental Medicine. 206: 2381-95. PMID 19808248 DOI: 10.1084/Jem.20091007 |
0.312 |
|
| 2009 |
Toffoli S, Delaive E, Dieu M, Feron O, Raes M, Michiels C. NDRG1 and CRK-I/II are regulators of endothelial cell migration under Intermittent Hypoxia. Angiogenesis. 12: 339-54. PMID 19760510 DOI: 10.1007/S10456-009-9156-2 |
0.363 |
|
| 2009 |
Feron O. Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 92: 329-33. PMID 19604589 DOI: 10.1016/J.Radonc.2009.06.025 |
0.363 |
|
| 2009 |
Frérart F, Lobysheva I, Gallez B, Dessy C, Feron O. Vascular caveolin deficiency supports the angiogenic effects of nitrite, a major end product of nitric oxide metabolism in tumors. Molecular Cancer Research : McR. 7: 1056-63. PMID 19567781 DOI: 10.1158/1541-7786.Mcr-08-0388 |
0.436 |
|
| 2009 |
Balligand J, Feron O, Dessy C. eNOS Activation by Physical Forces: From Short-Term Regulation of Contraction to Chronic Remodeling of Cardiovascular Tissues Physical Review. 89: 481-534. PMID 19342613 DOI: 10.1152/Physrev.00042.2007 |
0.598 |
|
| 2009 |
Toffoli S, Roegiers A, Feron O, Van Steenbrugge M, Ninane N, Raes M, Michiels C. Intermittent hypoxia is an angiogenic inducer for endothelial cells: role of HIF-1. Angiogenesis. 12: 47-67. PMID 19184477 DOI: 10.1007/S10456-009-9131-Y |
0.347 |
|
| 2009 |
Sonveaux P, Jordan BF, Gallez B, Feron O. Nitric oxide delivery to cancer: why and how? European Journal of Cancer (Oxford, England : 1990). 45: 1352-69. PMID 19153039 DOI: 10.1016/J.Ejca.2008.12.018 |
0.312 |
|
| 2009 |
Martinive P, Defresne F, Quaghebeur E, Daneau G, Crokart N, Grégoire V, Gallez B, Dessy C, Feron O. Impact of cyclic hypoxia on HIF-1alpha regulation in endothelial cells--new insights for anti-tumor treatments. The Febs Journal. 276: 509-18. PMID 19077164 DOI: 10.1111/J.1742-4658.2008.06798.X |
0.374 |
|
| 2008 |
Sonveaux P, Végran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, De Saedeleer CJ, Kennedy KM, Diepart C, Jordan BF, Kelley MJ, Gallez B, Wahl ML, Feron O, Dewhirst MW. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. The Journal of Clinical Investigation. 118: 3930-42. PMID 19033663 DOI: 10.1172/Jci36843 |
0.37 |
|
| 2008 |
Beck R, Verrax J, Gonze T, Zappone M, Pedrosa RC, Taper H, Feron O, Calderon PB. Hsp90 cleavage by an oxidative stress leads to its client proteins degradation and cancer cell death. Biochemical Pharmacology. 77: 375-83. PMID 19014912 DOI: 10.1016/J.Bcp.2008.10.019 |
0.304 |
|
| 2008 |
Frérart F, Sonveaux P, Rath G, Smoos A, Meqor A, Charlier N, Jordan BF, Saliez J, Noël A, Dessy C, Gallez B, Feron O. The acidic tumor microenvironment promotes the reconversion of nitrite into nitric oxide: towards a new and safe radiosensitizing strategy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 2768-74. PMID 18451244 DOI: 10.1158/1078-0432.Ccr-07-4001 |
0.355 |
|
| 2008 |
Desjardins F, Lobysheva I, Pelat M, Gallez B, Feron O, Dessy C, Balligand JL. Control of blood pressure variability in caveolin-1-deficient mice: role of nitric oxide identified in vivo through spectral analysis. Cardiovascular Research. 79: 527-36. PMID 18349137 DOI: 10.1093/Cvr/Cvn080 |
0.594 |
|
| 2008 |
Gérard AC, Poncin S, Caetano B, Sonveaux P, Audinot JN, Feron O, Colin IM, Soncin F. Iodine deficiency induces a thyroid stimulating hormone-independent early phase of microvascular reshaping in the thyroid. The American Journal of Pathology. 172: 748-60. PMID 18276786 DOI: 10.2353/Ajpath.2008.070841 |
0.32 |
|
| 2008 |
Saliez J, Bouzin C, Rath G, Ghisdal P, Desjardins F, Rezzani R, Rodella LF, Vriens J, Nilius B, Feron O, Balligand JL, Dessy C. Role of caveolar compartmentation in endothelium-derived hyperpolarizing factor-mediated relaxation: Ca2+ signals and gap junction function are regulated by caveolin in endothelial cells. Circulation. 117: 1065-74. PMID 18268148 DOI: 10.1161/Circulationaha.107.731679 |
0.566 |
|
| 2008 |
Cron GO, Beghein N, Ansiaux R, Martinive P, Feron O, Gallez B. 19F NMR in vivo spectroscopy reflects the effectiveness of perfusion-enhancing vascular modifiers for improving gemcitabine chemotherapy. Magnetic Resonance in Medicine. 59: 19-27. PMID 18050344 DOI: 10.1002/Mrm.21469 |
0.31 |
|
| 2007 |
Bouchat V, Nuttens VE, Lucas S, Michiels C, Masereel B, Féron O, Gallez B, Borght TV. Radioimmunotherapy with radioactive nanoparticles: First results of dosimetry for vascularized and necrosed solid tumors. Medical Physics. 34: 4504-4513. PMID 28523697 DOI: 10.1118/1.2791038 |
0.308 |
|
| 2007 |
Dewever J, Frérart F, Bouzin C, Baudelet C, Ansiaux R, Sonveaux P, Gallez B, Dessy C, Feron O. Caveolin-1 is critical for the maturation of tumor blood vessels through the regulation of both endothelial tube formation and mural cell recruitment. The American Journal of Pathology. 171: 1619-28. PMID 17916598 DOI: 10.2353/Ajpath.2007.060968 |
0.396 |
|
| 2007 |
Jordan BF, Christian N, Crokart N, Grégoire V, Feron O, Gallez B. Thyroid status is a key modulator of tumor oxygenation: implication for radiation therapy. Radiation Research. 168: 428-32. PMID 17903037 DOI: 10.1667/Rr0931.1 |
0.321 |
|
| 2007 |
Toffoli S, Feron O, Raes M, Michiels C. Intermittent hypoxia changes HIF-1alpha phosphorylation pattern in endothelial cells: unravelling of a new PKA-dependent regulation of HIF-1alpha. Biochimica Et Biophysica Acta. 1773: 1558-71. PMID 17662481 DOI: 10.1016/J.Bbamcr.2007.06.002 |
0.357 |
|
| 2007 |
Sonveaux P, Lobysheva II, Feron O, McMahon TJ. Transport and peripheral bioactivities of nitrogen oxides carried by red blood cell hemoglobin: role in oxygen delivery. Physiology (Bethesda, Md.). 22: 97-112. PMID 17420301 DOI: 10.1152/Physiol.00042.2006 |
0.316 |
|
| 2007 |
Kupatt C, Hinkel R, von Brühl ML, Pohl T, Horstkotte J, Raake P, El Aouni C, Thein E, Dimmeler S, Feron O, Boekstegers P. Endothelial nitric oxide synthase overexpression provides a functionally relevant angiogenic switch in hibernating pig myocardium. Journal of the American College of Cardiology. 49: 1575-84. PMID 17418299 DOI: 10.1016/J.Jacc.2006.11.047 |
0.365 |
|
| 2007 |
Sonveaux P, Frérart F, Bouzin C, Brouet A, Dewever J, Jordan BF, Gallez B, Feron O. Irradiation promotes Akt-targeting therapeutic gene delivery to the tumor vasculature. International Journal of Radiation Oncology, Biology, Physics. 67: 1155-62. PMID 17276618 DOI: 10.1016/J.Ijrobp.2006.11.031 |
0.343 |
|
| 2007 |
Crokart N, Jordan BF, Baudelet C, Cron GO, Hotton J, Radermacher K, Grégoire V, Beghein N, Martinive P, Bouzin C, Feron O, Gallez B. Glucocorticoids modulate tumor radiation response through a decrease in tumor oxygen consumption. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 630-5. PMID 17255286 DOI: 10.1158/1078-0432.Ccr-06-0802 |
0.312 |
|
| 2007 |
Bouzin C, Brouet A, Vriese JD, DeWever J, Feron O. Effects of vascular endothelial growth factor on the lymphocyte-endothelium interactions: identification of caveolin-1 and nitric oxide as control points of endothelial cell anergy. Journal of Immunology. 178: 1505-1511. PMID 17237399 DOI: 10.4049/Jimmunol.178.3.1505 |
0.402 |
|
| 2007 |
Martinive P, Defresne F, Bouzin C, Saliez J, Lair F, Grégoire V, Michiels C, Dessy C, Feron O. Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies. Cancer Research. 66: 11736-44. PMID 17178869 DOI: 10.1158/0008-5472.Can-06-2056 |
0.368 |
|
| 2007 |
Dubroca C, Loyer X, Retailleau K, Loirand G, Pacaud P, Feron O, Balligand JL, Lévy BI, Heymes C, Henrion D. RhoA activation and interaction with Caveolin-1 are critical for pressure-induced myogenic tone in rat mesenteric resistance arteries. Cardiovascular Research. 73: 190-7. PMID 17150200 DOI: 10.1016/J.Cardiores.2006.10.020 |
0.549 |
|
| 2007 |
Ansiaux R, Baudelet C, Jordan BF, Crokart N, Martinive P, DeWever J, Grégoire V, Feron O, Gallez B. Mechanism of reoxygenation after antiangiogenic therapy using SU5416 and its importance for guiding combined antitumor therapy. Cancer Research. 66: 9698-704. PMID 17018628 DOI: 10.1158/0008-5472.Can-06-1854 |
0.35 |
|
| 2007 |
Sonveaux P, Feron O, McMahon T, Stamler J, Dewhirst M. C34. Oxygen regulation of tumor perfusion unravels the central pressor activity of cell-free human S-nitrosohemoglobin Nitric Oxide. 17: 28. DOI: 10.1016/J.Niox.2007.09.079 |
0.319 |
|
| 2007 |
Féron O. A23. Impact of the modulation of endothelial-derived NO in tumors on anticancer therapies Nitric Oxide. 17: 14. DOI: 10.1016/J.Niox.2007.09.028 |
0.308 |
|
| 2006 |
Martinive P, De Wever J, Bouzin C, Baudelet C, Sonveaux P, Grégoire V, Gallez B, Feron O. Reversal of temporal and spatial heterogeneities in tumor perfusion identifies the tumor vascular tone as a tunable variable to improve drug delivery. Molecular Cancer Therapeutics. 5: 1620-7. PMID 16818522 DOI: 10.1158/1535-7163.Mct-05-0472 |
0.336 |
|
| 2006 |
Batova S, DeWever J, Godfraind T, Balligand JL, Dessy C, Feron O. The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells. Cardiovascular Research. 71: 478-85. PMID 16814758 DOI: 10.1016/J.Cardiores.2006.04.013 |
0.583 |
|
| 2006 |
Sbaa E, Dewever J, Martinive P, Bouzin C, Frérart F, Balligand JL, Dessy C, Feron O. Caveolin plays a central role in endothelial progenitor cell mobilization and homing in SDF-1-driven postischemic vasculogenesis. Circulation Research. 98: 1219-27. PMID 16601228 DOI: 10.1161/01.Res.0000220648.80170.8B |
0.589 |
|
| 2006 |
Ansiaux R, Baudelet C, Cron GO, Segers J, Dessy C, Martinive P, De Wever J, Verrax J, Wauthier V, Beghein N, Grégoire V, Buc Calderon P, Feron O, Gallez B. Botulinum toxin potentiates cancer radiotherapy and chemotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 1276-83. PMID 16489084 DOI: 10.1158/1078-0432.Ccr-05-1222 |
0.347 |
|
| 2006 |
Feron O, Balligand JL. Caveolins and the regulation of endothelial nitric oxide synthase in the heart. Cardiovascular Research. 69: 788-97. PMID 16483868 DOI: 10.1016/J.Cardiores.2005.12.014 |
0.613 |
|
| 2006 |
Baudelet C, Cron GO, Ansiaux R, Crokart N, DeWever J, Feron O, Gallez B. The role of vessel maturation and vessel functionality in spontaneous fluctuations of T2*-weighted GRE signal within tumors. Nmr in Biomedicine. 19: 69-76. PMID 16411170 DOI: 10.1002/Nbm.1002 |
0.337 |
|
| 2006 |
Chantrain CF, Henriet P, Jodele S, Emonard H, Feron O, Courtoy PJ, DeClerck YA, Marbaix E. Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases. European Journal of Cancer (Oxford, England : 1990). 42: 310-8. PMID 16406506 DOI: 10.1016/J.Ejca.2005.11.010 |
0.323 |
|
| 2006 |
Sbaa E, Frérart F, Feron O. The double regulation of endothelial nitric oxide synthase by caveolae and caveolin: a paradox solved through the study of angiogenesis. Trends in Cardiovascular Medicine. 15: 157-62. PMID 16165011 DOI: 10.1016/J.Tcm.2005.05.006 |
0.407 |
|
| 2006 |
Dessy C, Saliez J, Ghisdal P, Daneau G, Lobysheva II, Frérart F, Belge C, Jnaoui K, Noirhomme P, Feron O, Balligand JL. Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol. Circulation. 112: 1198-205. PMID 16116070 DOI: 10.1161/Circulationaha.104.532960 |
0.526 |
|
| 2005 |
Crokart N, Radermacher K, Jordan BF, Baudelet C, Cron GO, Grégoire V, Beghein N, Bouzin C, Feron O, Gallez B. Tumor radiosensitization by antiinflammatory drugs: evidence for a new mechanism involving the oxygen effect. Cancer Research. 65: 7911-6. PMID 16140962 DOI: 10.1158/0008-5472.Can-05-1288 |
0.332 |
|
| 2005 |
Pfosser A, Thalgott M, Büttner K, Brouet A, Feron O, Boekstegers P, Kupatt C. Liposomal Hsp90 cDNA induces neovascularization via nitric oxide in chronic ischemia. Cardiovascular Research. 65: 728-36. PMID 15664400 DOI: 10.1016/J.Cardiores.2004.10.019 |
0.322 |
|
| 2005 |
Feron O. Chapter 5 The Caveolin Interaction with Endothelial Nitric Oxide Synthase (eNOS) Advances in Molecular and Cell Biology. 36: 89-108. DOI: 10.1016/S1569-2558(05)36005-X |
0.409 |
|
| 2004 |
Brouet A, DeWever J, Martinive P, Havaux X, Bouzin C, Sonveaux P, Feron O. Antitumor effects of in vivo caveolin gene delivery are associated with the inhibition of the proangiogenic and vasodilatory effects of nitric oxide. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 602-4. PMID 15623570 DOI: 10.1096/Fj.04-2682Fje |
0.398 |
|
| 2004 |
Massion PB, Dessy C, Desjardins F, Pelat M, Havaux X, Belge C, Moulin P, Guiot Y, Feron O, Janssens S, Balligand JL. Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction. Circulation. 110: 2666-72. PMID 15492314 DOI: 10.1161/01.Cir.0000145608.80855.Bc |
0.581 |
|
| 2004 |
Feron O. Targeting the tumor vascular compartment to improve conventional cancer therapy. Trends in Pharmacological Sciences. 25: 536-42. PMID 15380938 DOI: 10.1016/J.Tips.2004.08.008 |
0.362 |
|
| 2004 |
Sonveaux P, Martinive P, DeWever J, Batova Z, Daneau G, Pelat M, Ghisdal P, Grégoire V, Dessy C, Balligand JL, Feron O. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis. Circulation Research. 95: 154-61. PMID 15205364 DOI: 10.1161/01.Res.0000136344.27825.72 |
0.607 |
|
| 2004 |
Sonveaux P, Dessy C, Martinive P, Havaux X, Jordan BF, Gallez B, Grégoire V, Balligand JL, Feron O. Endothelin-1 is a critical mediator of myogenic tone in tumor arterioles: implications for cancer treatment. Cancer Research. 64: 3209-14. PMID 15126361 DOI: 10.1158/0008-5472.Can-03-1291 |
0.574 |
|
| 2004 |
Attia DM, Feron O, Goldschmeding R, Radermakers LH, Vaziri ND, Boer P, Balligand JL, Koomans HA, Joles JA. Hypercholesterolemia in rats induces podocyte stress and decreases renal cortical nitric oxide synthesis via an angiotensin II type 1 receptor-sensitive mechanism. Journal of the American Society of Nephrology : Jasn. 15: 949-57. PMID 15034097 DOI: 10.1097/01.Asn.0000118528.00817.8E |
0.517 |
|
| 2004 |
Jordan BF, Sonveaux P, Feron O, Grégoire V, Beghein N, Dessy C, Gallez B. Nitric oxide as a radiosensitizer: evidence for an intrinsic role in addition to its effect on oxygen delivery and consumption. International Journal of Cancer. 109: 768-73. PMID 14999787 DOI: 10.1002/Ijc.20046 |
0.346 |
|
| 2003 |
Ni J, Moulin P, Gianello P, Feron O, Balligand JL, Devuyst O. Mice that lack endothelial nitric oxide synthase are protected against functional and structural modifications induced by acute peritonitis. Journal of the American Society of Nephrology : Jasn. 14: 3205-16. PMID 14638919 DOI: 10.1097/01.Asn.0000099382.18284.57 |
0.57 |
|
| 2003 |
Rezzani R, Rodella L, Dessy C, Daneau G, Bianchi R, Feron O. Changes in Hsp90 expression determine the effects of cyclosporine A on the NO pathway in rat myocardium. Febs Letters. 552: 125-9. PMID 14527673 DOI: 10.1016/S0014-5793(03)00898-6 |
0.315 |
|
| 2003 |
Massion PB, Feron O, Dessy C, Balligand JL. Nitric oxide and cardiac function: ten years after, and continuing. Circulation Research. 93: 388-98. PMID 12958142 DOI: 10.1161/01.Res.0000088351.58510.21 |
0.595 |
|
| 2003 |
Pelat M, Dessy C, Massion P, Desager JP, Feron O, Balligand JL. Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/- mice in vivo. Circulation. 107: 2480-6. PMID 12719275 DOI: 10.1161/01.Cir.0000065601.83526.3E |
0.564 |
|
| 2003 |
Sonveaux P, Brouet A, Havaux X, Grégoire V, Dessy C, Balligand JL, Feron O. Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy. Cancer Research. 63: 1012-9. PMID 12615716 |
0.571 |
|
| 2003 |
Jordan BF, Sonveaux P, Feron O, Grégoire V, Beghein N, Gallez B. Nitric oxide-mediated increase in tumor blood flow and oxygenation of tumors implanted in muscles stimulated by electric pulses. International Journal of Radiation Oncology, Biology, Physics. 55: 1066-73. PMID 12605986 DOI: 10.1016/S0360-3016(02)04505-4 |
0.307 |
|
| 2003 |
Kupatt C, Hinkel R, Vachenauer R, Horstkotte J, Raake P, Sandner T, Kreuzpointner R, Müller F, Dimmeler S, Feron O, Boekstegers P. VEGF165 transfection decreases postischemic NF-kappa B-dependent myocardial reperfusion injury in vivo: role of eNOS phosphorylation. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 17: 705-7. PMID 12586740 DOI: 10.1096/Fj.02-0673Fje |
0.352 |
|
| 2003 |
Piech A, Dessy C, Havaux X, Feron O, Balligand JL. Differential regulation of nitric oxide synthases and their allosteric regulators in heart and vessels of hypertensive rats. Cardiovascular Research. 57: 456-67. PMID 12566118 DOI: 10.1016/S0008-6363(02)00676-4 |
0.57 |
|
| 2003 |
Pelat M, Dessy C, Massion P, Desager J, Feron O, Balligand J. 4P-1061 Altered blood pressure and heart rate variability in hypercholesterolemic apoE-/-mice is corrected by rosuvastatin independently of its plasma lipid lowering activity Atherosclerosis Supplements. 4: 308. DOI: 10.1016/S1567-5688(03)91318-3 |
0.46 |
|
| 2002 |
Vincent KA, Feron O, Kelly RA. Harnessing the response to tissue hypoxia: HIF-1 alpha and therapeutic angiogenesis. Trends in Cardiovascular Medicine. 12: 362-7. PMID 12536123 DOI: 10.1016/S1050-1738(02)00186-X |
0.338 |
|
| 2002 |
Sonveaux P, Dessy C, Brouet A, Jordan BF, Grégoire V, Gallez B, Balligand JL, Feron O. Modulation of the tumor vasculature functionality by ionizing radiation accounts for tumor radiosensitization and promotes gene delivery. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 16: 1979-81. PMID 12397083 DOI: 10.1096/Fj.02-0487Fje |
0.591 |
|
| 2002 |
Persu A, Stoenoiu MS, Messiaen T, Davila S, Robino C, El-Khattabi O, Mourad M, Horie S, Feron O, Balligand JL, Wattiez R, Pirson Y, Chauveau D, Lens XM, Devuyst O. Modifier effect of ENOS in autosomal dominant polycystic kidney disease Human Molecular Genetics. 11: 229-241. PMID 11823442 DOI: 10.1093/Hmg/11.3.229 |
0.535 |
|
| 2002 |
Piech A, Massart P, Dessy C, Feron O, Havaux X, Morel N, Vanoverschelde J, Donckier J, Balligand J. Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy American Journal of Physiology-Heart and Circulatory Physiology. 282. PMID 11748066 DOI: 10.1152/Ajpheart.2002.282.1.H219 |
0.59 |
|
| 2001 |
Brouet A, Sonveaux P, Dessy C, Moniotte S, Balligand JL, Feron O. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins. Circulation Research. 89: 866-73. PMID 11701613 DOI: 10.1161/Hh2201.100319 |
0.591 |
|
| 2001 |
Brouet A, Sonveaux P, Dessy C, Balligand JL, Feron O. Hsp90 ensures the transition from the early Ca2+-dependent to the late phosphorylation-dependent activation of the endothelial nitric-oxide synthase in vascular endothelial growth factor-exposed endothelial cells. The Journal of Biological Chemistry. 276: 32663-9. PMID 11425855 DOI: 10.1074/Jbc.M101371200 |
0.592 |
|
| 2001 |
Moniotte S, Kobzik L, Feron O, Trochu JN, Gauthier C, Balligand JL. Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation. 103: 1649-55. PMID 11273992 DOI: 10.1161/01.Cir.103.12.1649 |
0.501 |
|
| 2001 |
Feron O, Kelly RA. The caveolar paradox: suppressing, inducing, and terminating eNOS signaling. Circulation Research. 88: 129-31. PMID 11157661 DOI: 10.1161/01.Res.88.2.129 |
0.313 |
|
| 2001 |
Feron O, Dessy C, Desager JP, Balligand JL. Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation. 103: 113-8. PMID 11136695 DOI: 10.1161/01.Cir.103.1.113 |
0.598 |
|
| 2000 |
Dessy C, Kelly RA, Balligand JL, Feron O. Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling. The Embo Journal. 19: 4272-80. PMID 10944110 DOI: 10.1093/Emboj/19.16.4272 |
0.563 |
|
| 1999 |
Feron O. Endothelial nitric oxide synthase expression and its functionality. Current Opinion in Clinical Nutrition and Metabolic Care. 2: 291-6. PMID 10453308 DOI: 10.1097/00075197-199907000-00007 |
0.385 |
|
| 1999 |
Feron O, Zhao YY, Kelly RA. The ins and outs of caveolar signaling. m2 muscarinic cholinergic receptors and eNOS activation versus neuregulin and ErbB4 signaling in cardiac myocytes. Annals of the New York Academy of Sciences. 874: 11-9. PMID 10415516 DOI: 10.1111/J.1749-6632.1999.Tb09220.X |
0.375 |
|
| 1999 |
Feron O, Dessy C, Moniotte S, Desager JP, Balligand JL. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. The Journal of Clinical Investigation. 103: 897-905. PMID 10079111 DOI: 10.1172/Jci4829 |
0.605 |
|
| 1999 |
Feron O, Han X, Kelly RA. Muscarinic cholinergic signaling in cardiac myocytes: dynamic targeting of M2AChR to sarcolemmal caveolae and eNOS activation. Life Sciences. 64: 471-7. PMID 10069512 DOI: 10.1016/S0024-3205(98)00590-6 |
0.394 |
|
| 1999 |
Feron O. Intracellular localization and activation of endothelial nitric oxide synthase. Current Opinion in Nephrology and Hypertension. 8: 55-9. PMID 9914861 DOI: 10.1097/00041552-199901000-00010 |
0.356 |
|
| 1998 |
Feron O, Dessy C, Opel DJ, Arstall MA, Kelly RA, Michel T. Modulation of the endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes. Implications for the autonomic regulation of heart rate. The Journal of Biological Chemistry. 273: 30249-54. PMID 9804784 DOI: 10.1074/Jbc.273.46.30249 |
0.607 |
|
| 1998 |
Han X, Kubota I, Feron O, Opel DJ, Arstall MA, Zhao YY, Huang P, Fishman MC, Michel T, Kelly RA. Muscarinic cholinergic regulation of cardiac myocyte ICa-L is absent in mice with targeted disruption of endothelial nitric oxide synthase. Proceedings of the National Academy of Sciences of the United States of America. 95: 6510-5. PMID 9600997 DOI: 10.1073/Pnas.95.11.6510 |
0.583 |
|
| 1998 |
Feron O, Saldana F, Michel JB, Michel T. The endothelial nitric-oxide synthase-caveolin regulatory cycle. The Journal of Biological Chemistry. 273: 3125-8. PMID 9452418 DOI: 10.1074/Jbc.273.6.3125 |
0.584 |
|
| 1998 |
Feron O, Michel JB, Sase K, Michel T. Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions. Biochemistry. 37: 193-200. PMID 9425039 DOI: 10.1021/Bi972307P |
0.594 |
|
| 1997 |
Michel T, Feron O. Nitric oxide synthases: which, where, how, and why? The Journal of Clinical Investigation. 100: 2146-52. PMID 9410890 DOI: 10.1172/Jci119750 |
0.545 |
|
| 1997 |
Michel JB, Feron O, Sase K, Prabhakar P, Michel T. Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. The Journal of Biological Chemistry. 272: 25907-12. PMID 9325323 DOI: 10.1074/Jbc.272.41.25907 |
0.582 |
|
| 1997 |
Feron O, Smith TW, Michel T, Kelly RA. Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes. The Journal of Biological Chemistry. 272: 17744-8. PMID 9211926 DOI: 10.1074/Jbc.272.28.17744 |
0.551 |
|
| 1997 |
Michel JB, Feron O, Sacks D, Michel T. Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin. The Journal of Biological Chemistry. 272: 15583-6. PMID 9188442 DOI: 10.1074/Jbc.272.25.15583 |
0.591 |
|
| 1997 |
Belhassen L, Feron O, Kaye DM, Michel T, Kelly RA. Regulation by cAMP of post-translational processing and subcellular targeting of endothelial nitric-oxide synthase (type 3) in cardiac myocytes. The Journal of Biological Chemistry. 272: 11198-204. PMID 9111020 DOI: 10.1074/Jbc.272.17.11198 |
0.598 |
|
| 1996 |
Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA, Michel T. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. The Journal of Biological Chemistry. 271: 22810-4. PMID 8798458 DOI: 10.1074/Jbc.271.37.22810 |
0.603 |
|
| Show low-probability matches. |